Indogulf Cropsciences saw Q1 FY27 revenue decline 11% YoY to Rs. 168.5 Cr due to delayed monsoons.

Despite this, gross margins improved significantly to 28% and EBITDA margins to 5.7%, reflecting strong cost and product mix discipline.

PAT was Rs. 2.4 Cr.

Management views Q1 weakness as temporary, focusing on expanding high-margin biologicals, specialty products, and international markets.

Capacity utilization rose to 70%, with 34% captive technical usage for efficiency.

The company aims to evolve into an integrated agri-solution platform, targeting Rs. 1800 Cr+ revenue in 4-5 years.

The outlook remains strategically driven for long-term growth.